Acer Therapeutics Inc. (ACER)
Acer Therapeutics Inc. (ACER)
$3.27 USD
Updated Sep 13 6:55pm
Add ACER to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
ACER Stock Chart More Charts
ACER Price/Volume Stats
| Current price | $3.27 |
| Prev. close | $3.16 |
| Day low | $3.13 |
| Day high | $3.35 |
| 50-day MA | $2.79 |
| 200-day MA | $16.23 |
| 52-week high | $32.75 |
| 52-week low | $1.87 |
| Volume | 78,900 |
| Avg. volume | 154,235 |
| Dividend yield | N/A |
| Market Cap | 33.01M |
Acer Therapeutics Inc. (ACER) Company Bio
Acer Therapeutics Inc., formerly Opexa Therapeutics, develops therapies for the treatment of serious ultra-rare diseases with critical unmet medical needs. The company offers Celiprolol for vascular ehlers-danlos syndrome and ACER-001 for maple syrup urine disease. It also offers advancing ACER-001 for the treatment of urea cycle disorders. The company was founded in 2013 and is based in Cambridge, Massachusetts.
Top Stories View All
101 Fresh Upgrades to Start the Week
2900 or 3100: Which Comes Next?
Best & Worst Performing Stock Industries for September 13, 2019
Best & Worst Performing Small Cap Stocks for September 13, 2019
Best & Worst Performing Large Cap Stocks for September 13, 2019
View All Top Stories
Loading social stream, please wait...